Ultrahuman has acquired women’s health technology firm viO HealthTech and introduced a new premium feature for its Ring AIR smart ring, named Cycle & Ovulation Pro, aimed at delivering more accurate and inclusive menstrual and fertility insights; the feature leverages viO’s OvuSense temperature-based algorithm—developed over 15 years using medical-grade datasets—to offer over 90% estimated accuracy in ovulation tracking, including support for users with irregular cycles due to conditions like PCOS or endometriosis, and is available now in the U.S., U.K., EU, Canada, and Australia at roughly $3.99/month or $39.99/year, while retaining the existing free Cycle & Ovulation PowerPlug as an option.
Sources: Android Central, Tom’s Guide, TechCrunch
Key Takeaways
– Clinically-backed accuracy: The new feature claims over 90% accuracy using the OvuSense algorithm trained on 260,000+ cycles and validated against hormone-based methods .
– Inclusive cycle tracking: Designed to serve users with diverse cycle patterns—including PCOS, endometriosis, thyroid issues—unlike typical 28-day focused trackers.
– Subscription model with a free tier maintained: Cycle & Ovulation Pro is a paid “PowerPlug” at ~$3.99/month or ~$39.99/year; the existing free PowerPlug remains available for basic tracking .
In-Depth
Ultrahuman’s acquisition of viO HealthTech and the launch of Cycle & Ovulation Pro is a calculated step forward in the women’s wellness space, bridging clinical accuracy with consumer convenience. The integration of viO’s OvuSense algorithm—backed by 15 years of R&D and a dataset exceeding 260,000 tracked cycles—underscores Ultrahuman’s commitment to reliable, evidence-based health tracking. Adapting the algorithm, originally cleared as a medical-grade intravaginal tool, to a non-invasive finger-worn smart ring represents a pragmatic transformation that can bring specialist-level tracking into everyday life—though it’s clearly marketed for “wellness,” not a substitute for medical advice.
In practice, Cycle & Ovulation Pro empowers users to move beyond the limitations of rigid 28-day cycle assumptions. By tracking temperature biomarkers and physiological patterns, it flags important variations—early or late ovulation, short luteal phases, missed ovulation—that can offer early clues to underlying conditions like PCOS or endometriosis. The user-friendly interface, paired with the ability to log mood, symptoms, and lifestyle factors, turns raw data into actionable insights—not diagnoses, but trends that might better inform personal health decisions or conversations with healthcare professionals.
The dual-tier model, retaining the existing free PowerPlug while offering the Pro upgrade for a modest fee, strikes a balanced approach: free baseline functionality ensures accessibility, while the premium option caters to users seeking richer insights. Launching in major markets like the U.S., Europe, U.K., Australia, and Canada sets a strong foundation; expansion to more regions seems inevitable. Overall, Ultrahuman’s move reflects a responsible, inclusive vision in wearable health—where advanced tracking meets practical affordability, underpinned by robust clinical heritage.